4 free views remaining today
Alzheimer's disease 3
ICD-10 Codes
Description
Alzheimer's Disease: A Progressive Condition
Alzheimer's disease causes trouble concentrating and thinking, especially about abstract concepts such as numbers [3]. This is because the disease affects the brain's ability to process information and perform complex tasks.
As a result, people with Alzheimer's may struggle with:
- Concentrating on multiple tasks at once
- Remembering phone numbers or addresses
- Performing calculations or solving math problems
- Understanding abstract concepts such as time, money, or relationships
This decline in cognitive function can be gradual, but it eventually becomes more severe [6]. It's essential to note that Alzheimer's disease is a progressive condition, meaning the symptoms develop gradually over many years and eventually become more severe.
Key Facts:
- Alzheimer's disease affects memory, thinking, and behavior
- Symptoms eventually grow severe enough to interfere with daily tasks
- The disease causes trouble concentrating and thinking, especially about abstract concepts such as numbers
- It's a progressive condition that develops gradually over many years
References: [3] Nov 8, 2024 — Alzheimer's disease causes trouble concentrating and thinking, especially about abstract concepts such as numbers. [6] Aug 15, 2024 — Alzheimer's disease is... · A brain disorder caused by damage to nerve cells in the brain. · Progressive, meaning that it develops gradually over ...
Additional Characteristics
- Concentrating on multiple tasks at once
- Remembering phone numbers or addresses
- Performing calculations or solving math problems
- Understanding abstract concepts such as time, money, or relationships
Signs and Symptoms
The Signs and Symptoms of Alzheimer’s Disease
Alzheimer's disease, a progressive neurological disorder, affects millions worldwide. The symptoms of Alzheimer's disease vary based on the stage of the condition, but generally involve a gradual decline in some or all of the following:
- Memory: One of the first signs of Alzheimer's is memory lapses, which can range from mild forgetfulness to complete loss of short-term and long-term memories.
- Reasoning and handling of complex tasks: As the disease progresses, individuals may struggle with problem-solving, decision-making, and performing daily tasks that require cognitive effort.
- Language: People with Alzheimer's may experience difficulties with word-finding, following conversations, or understanding written text.
- Understanding visual form and space relationships: This symptom can manifest as difficulty navigating familiar environments, judging distances, or perceiving spatial relationships.
These symptoms often appear in the early stages of Alzheimer's disease and can worsen over time. It is essential to note that each person experiences the progression of the disease differently, and the rate at which symptoms develop can vary significantly from one individual to another.
References:
- [3] Early symptoms.
- [10] The symptoms of Alzheimer’s can vary from one person to another.
- [4] Generally, the symptoms of Alzheimer's disease are divided into 3 main stages.
Additional Symptoms
- Memory
- Reasoning and handling of complex tasks
- Language
- Understanding visual form and space relationships
Diagnostic Tests
Diagnostic Tests for Alzheimer's Disease
To diagnose Alzheimer's dementia, healthcare professionals conduct tests to measure memory impairment and other thinking skills [3]. These tests are crucial in determining the presence and severity of the disease.
Some common diagnostic tests used to assess cognitive function include:
- Medical History: A thorough review of a patient's medical history is essential in identifying potential risk factors for Alzheimer's disease, such as family history or previous head injuries.
- Mental Status Tests: These tests evaluate a person's mental status by assessing their memory, language skills, and problem-solving abilities. Examples include the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).
- Neuropsychological Screening Tests: These tests are designed to assess various cognitive functions, such as attention, executive function, and visuospatial skills.
- Blood Tests: Blood tests can help identify underlying conditions that may be contributing to memory problems or other symptoms of Alzheimer's disease.
It is essential to note that a definitive diagnosis of Alzheimer's disease can only be made through a comprehensive evaluation by a healthcare professional, taking into account the results of these diagnostic tests and other factors [4].
References:
[3] Mar 13, 2024 — To diagnose Alzheimer's dementia, healthcare professionals conduct tests to measure memory impairment and other thinking skills. [4] Apr 13, 2024 — To diagnose Alzheimer's, physicians may use medical history, mental status tests, physical and neurological exams, diagnostic tests and brain imaging.
Additional Diagnostic Tests
- Blood Tests
- Medical History
- Mental Status Tests
- Neuropsychological Screening Tests
Treatment
Treatment Options for Early- to Mid-Stage Alzheimer's Disease
For individuals with early- to mid-stage Alzheimer's disease, there are several drug treatment options available. These medications can help manage symptoms and slow down the progression of the disease.
- Donepezil: This medication is approved to treat all stages of Alzheimer's disease. It works by blocking the action of acetylcholinesterase, an enzyme responsible for destroying a chemical called acetylcholine. Acetylcholine is one of the chemicals that helps with memory and learning.
- Galantamine: This drug is also used to treat mild to moderate Alzheimer's disease. Like donepezil, it works by blocking the action of acetylcholinesterase.
- Rivastigmine: This medication can be prescribed for people with early- to mid-stage Alzheimer's disease. It can also be applied as a patch.
These medications are not a cure for Alzheimer's disease, but they may help improve symptoms and slow down the progression of the disease. It's essential to consult with a healthcare professional to determine the best treatment plan for an individual's specific needs.
References: * [3] Donepezil, galantamine and rivastigmine can be prescribed for people with early- to mid-stage Alzheimer's disease. * [4] These drugs work by blocking the action of acetylcholinesterase, the enzyme responsible for destroying acetylcholine.
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Accurate diagnosis of Alzheimer's disease can be complicated by other forms of dementia that have similar symptoms and pathologies.
To accurately diagnose Alzheimer's disease, it is essential to consider the key features and pathology of each type of dementia. This knowledge will help healthcare professionals provide the appropriate treatment and support services for patients with Alzheimer's disease.
According to the Alzheimer's Association, accurate diagnosis may be complicated by other causes of dementia that have symptoms and pathologies similar to Alzheimer's disease [1]. Knowing the key clinical manifestations of each type of dementia can aid in the differential diagnosis of patients, ensuring they receive the correct treatment and support services for their condition.
The differential diagnosis includes degenerative (Alzheimer's, Parkinson's, or Pick's disease), emotional (depression), metabolic (organ failure), neoplastic (cancer-related) causes, among others [6]. A comprehensive understanding of these factors is crucial for healthcare professionals to make an accurate diagnosis and provide the necessary care for patients with Alzheimer's disease.
References: [1] Context 1 [6] Context 6
Additional Differential Diagnoses
- degenerative (Alzheimer's, Parkinson's, or Pick's disease)
- emotional (depression)
- metabolic (organ failure)
- neoplastic (cancer-related)
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4396
- owl#annotatedSource
- t366348
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0110042
- core#notation
- DOID:0110042
- oboInOwl#hasDbXref
- MIM:607822
- oboInOwl#hasExactSynonym
- Alzheimer disease familial 3
- rdf-schema#label
- Alzheimer's disease 3
- IAO_0000115
- An Alzheimer's disease that has_material_basis_in mutation in the presenilin-1 gene (PSEN1) on chromosome 14q24.
- rdf-schema#subClassOf
- t366073
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- relatedICD
- http://example.org/icd10/G30.8
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.